Compare KARD & EVCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KARD | EVCM |
|---|---|---|
| Founded | 2023 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | EDP Services |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2026 | 2021 |
| Metric | KARD | EVCM |
|---|---|---|
| Price | $11.56 | $6.47 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 8 |
| Target Price | ★ $41.00 | $8.25 |
| AVG Volume (30 Days) | ★ 441.3K | 89.0K |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 145.45 |
| EPS | N/A | ★ 0.13 |
| Revenue | N/A | ★ $588,907,000.00 |
| Revenue This Year | N/A | $1.89 |
| Revenue Next Year | N/A | $2.74 |
| P/E Ratio | ★ N/A | $46.38 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.23 | $5.59 |
| 52 Week High | $27.00 | $14.41 |
| Indicator | KARD | EVCM |
|---|---|---|
| Relative Strength Index (RSI) | 35.74 | 29.68 |
| Support Level | N/A | $6.11 |
| Resistance Level | $16.26 | $10.05 |
| Average True Range (ATR) | 1.30 | 0.77 |
| MACD | -0.24 | -0.18 |
| Stochastic Oscillator | 0.60 | 27.15 |
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. The Company served more than 745,000 customers across three core verticals: EverPro for Home Services; EverHealth for Health Services; and EverWell for Wellness Services. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty.